Possible Role of Roflumilast in Diabetic Nephropathy

Summary

adding roflumilast to the standard therapy for diabetic nephropathy and studying the progression of many outcomes including urinary albumin to creatinine ratio, estimated GFR, biomarkers of diabetic nephropathy

Timeline

Start

2021-03-10

Primary completion

2021-06-10

Completion

2021-07-10

Drugs

Indications